http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
UV-curing kinetics and performance development of <i>in situ</i> curable 3D printing materials
Kim, Ye Chan,Hong, Sungyong,Sun, Hanna,Kim, Myeong Gi,Choi, Kisuk,Cho, Jungkeun,Choi, Hyouk Ryeol,Koo, Ja Choon,Moon, Hyungpil,Byun, Doyoung,Kim, Kwang J.,Suhr, Jonghwan,Kim, Soo Hyun,Nam, Jae-Do Elsevier 2017 European polymer journal Vol.93 No.-
<P><B>Abstract</B></P> <P>As three-dimensional (3D) printing technology is emerging as an alternative way of manufacturing, the high resolution 3D printing device often requires systems such as drop jetting printing of <I>in situ</I> UV-curable photopolymers. Accordingly, the key issue is process control and its optimization to ensure dimensional accuracy, surface roughness, building orientation, and mechanical properties of printed structures, which are based on the time- and temperature-dependent glass transition temperature (<I>T<SUB>g</SUB> </I>) of the resin system under UV-curing. In this study, the UV-cure kinetics and <I>T<SUB>g</SUB> </I> development of a commercially available UV-curable acrylic resin system were investigated as a model system, using a differential scanning photocalorimeter (DPC). The developed kinetic model included the limited conversion of cure that could be achieved as a maximum at a specific isothermal curing temperature. Using the developed model, the <I>T<SUB>g</SUB> </I> was successfully described by a modified DiBenedetto equation as a function of UV curing. The developed kinetic model and <I>T<SUB>g</SUB> </I> development can be used to determine the 3D printing operating conditions for the overlay printing and <I>in situ</I> UV curing, which could ensure high-resolution and high-speed manufacturing with various UV-curing materials.</P> <P><B>Highlights</B></P> <P> <UL> <LI> UV-cure kinetic analysis were applied to a commercial Multi-jet 3D printing material. </LI> <LI> The developed kinetic model included the limited conversion of cure by temperature. </LI> <LI> The <I>T<SUB>g</SUB> </I> was described by a modified DiBenedetto equation as a function of UV curing. </LI> <LI> The developed kinetic model showed an excellent agreement to isothermal experiments. </LI> <LI> The overlay printing time for each isothermal temperature was determined. </LI> </UL> </P> <P><B>Graphical abstract</B></P> <P>[DISPLAY OMISSION]</P>
Tranexamic Acid in Trauma Management: A Review of Evidence
Nam-Ryeol Kim 대한외상중환자외과학회 2023 Journal of Acute Care Surgery Vol.13 No.3
Hemorrhage is the leading cause of death in trauma patients and trauma induced coagulopathy (TIC) is a major contributor to bleeding mortality. TIC has a diverse pathophysiology triggered by injury and hypoperfusion, including platelet dysfunction, endotheliopathy, fibrinogen or thrombin abnormalities, and dysregulated fibrinolysis. Early fluid resuscitation, appropriate blood transfusion, and definitive control of bleeding are essential components of initial management for TIC. Additionally, tranexamic acid (TXA), an antifibrinolytic agent, has emerged as a potential adjunctive therapy following the 2010 landmark trial that demonstrated the benefit of early administration of TXA in reducing trauma patient mortality (CRASH-2). This review provides an analysis of the current literature on the use of TXA in trauma patients. It critically evaluates the evidence on the effect of TXA on TIC and other clinical outcomes, emphasizing the time-sensitive nature of TXA administration and the variation of its effect depending on the severity and location of injury. It also discusses the optimal dosage, timing, and safety of TXA, as well as the challenges and limitations of existing studies. Furthermore, it highlights the importance of individualized treatment approaches based on the fibrinolysis status of TIC and the value of goal-directed therapy guided by viscoelastic hemostatic assays for the appropriate use of TXA.